iifl-logo

Centenial Surgical Suture Ltd Board Meeting

Add as a Preferred Source on Google
₹91.28
(4.99%)
Nov 18, 2026|04:01:00 PM

Centenial Surgic CORPORATE ACTIONS

18/11/2025calendar-icon
18/11/2026calendar-icon
PurposeBoard Meetings DateAnnouncement Date
Board Meeting12 Nov 20265 Nov 2026
Centenial Surgical Suture Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2026 inter alia to consider and approve 1. To approve Standalone Un-Audited Financial Results for the quarter & half year ended on September 30 2026 pursuant to Regulation 33 of SEBI (LODR) Regulation 2015. 2. To consider the proposal for raising of funds by way of equity shares or any other securities through permissible modes including but not limited to a rights issue or preferential issue or qualified institutions placement or any other method or a combination thereof as may be permitted under applicable laws including the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations 2018 and the Companies Act 2013 as amended and subject to receipt of regulatory / statutory / necessary approvals as may be required. 3. Any other business with the permission of chair. 1. The Standalone Un-Audited Financial Results for the quarter and half year ended September 30, 2026 along with the Limited Review Report of the Statutory Auditors. 2. Taken on record resignation of Anuradha Kashikar (DIN : 00804831), Whole Time Director w.e.f. October 5, 2026. 3. The Board of Directors inter alia, considered the proposal for raising funds through various permissible modes. After due deliberations, the Board decided that, prior to taking any decision regarding the proposed fund-raising, it would be prudent and in the best interests of the Company and its shareholders to undertake a comprehensive independent assessment of the financial viability, commercial feasibility, associated risks, regulatory implications, and due diligence requirements of the available fund-raising alternatives. please find attached (As Per BSE Announcement Dated 12.11.2026)
Board Meeting14 Aug 20263 Aug 2026
Quarterly Results & A.G.M. AS PER ATTACHMENT (As Per BSE Announcement Dated on:14.08.2026)
Board Meeting30 May 202623 May 2026
Centenial Surgical Suture Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve 1) To approve Standalone Audited Financial Results along with Auditors Report for the quarter and year ended on March 31 2026 pursuant to Regulation 33 of SEBI (LODR) Regulations 2015. 2) Any other business with the permission of chair. The approved results will be uploaded on BSE Limited website after conclusion of the said meeting. Board Meeting Outcome for Outcome Of The Board Meeting Held On May 30 2026, Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements [LODR]) Regulations, 2015 (As Per BSE Announcement Dated on: 30/05/2026)
Board Meeting12 Feb 20267 Feb 2026
Centenial Surgical Suture Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 inter alia to consider and approve 1. Standalone Un-Audited Financial Results for the quarter ended on December 31 2025 pursuant to Regulation 33 of SEBI (LODR) Regulation 2015. 2. Any other business with the permission of chair. PFA (As Per BSE Announcement Dated on 12.02.2026)

Centenial Surgic: Related News

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited. All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.